Intriguingly, while ISG15-mediated restoration of fork protection has been consistently observed in all cellular systems we have tested, the acquisition of drug resistance appears to be rather tumor and cell type-specific, probably depending on the complexity of the genetic background. This evidence concerns the gene ISG15 and neoplasm.